Sign in

CIK 0001853816

  • Emerging growth company

Dermata Therapeutics, Inc.

Sign in to watch
Ticker
DRMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 858-223-0882
Business address
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
Former names
Dermata Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-02 Nardo Christopher J. Senior VP, CDO Grant or award · Stock Option (right to buy) +18,000 18,000
2025-01-13 Nardo Christopher J. Senior VP, CDO Grant or award · Stock Option (right to buy) +20,000 20,000
2024-01-04 Nardo Christopher J. Senior VP, CDO Grant or award · Stock Option (right to buy +50,000 50,000
2023-01-03 Nardo Christopher J. Senior VP, CDO Grant or award · Stock Option (right to buy) +100,000 100,000
2022-07-01 Nardo Christopher J. Senior VP, CDO Grant or award · Stock Option (right to buy) +30,000 30,000
2022-01-03 Nardo Christopher J. Senior VP, Development Grant or award · Stock Option (right to buy) +30,000 30,000
2021-08-17 Nardo Christopher J. Senior VP, Development Conversion +2,439 2,439
2021-08-17 Nardo Christopher J. Senior VP, Development Conversion · Series 1 Preferred Stock −50,000 0

Page 1 of 1 · 8 trades